Liver damage and hepatomegaly in COVID-19 patients
Conclusions: Patients who need to be hospitalized with COVID-19 and who do not have acute and/or chronic liver disease, elevated liver function test results, and an increase in liver sizes at presentation, it was seen that these did not have an effect on the clinical outcome. However, in addition to the presence of advanced age and comorbidity, the presence of hepatomegaly measured by CT at admission, and high LDH and CK levels were associated with poor clinical outcomes.
Source: The Journal of Infection in Developing Countries - Category: Infectious Diseases Authors: P ınar Yürük Atasoy, Engin Beydoğan Source Type: research
More News: COVID-19 | Emergency Medicine | Hepatomegaly | Infectious Diseases | Intensive Care | Liver | Liver Disease | Study | Urology & Nephrology